3M secures another settlement in price-gouging campaign
22-07-2020
DOJ chief wades into dental antitrust case in rare intervention
09-07-2020
DoJ sues company for selling unapproved drugs and supplements
21-02-2017
traveler1116 / iStockphoto.com
Two citizens of Ukraine have admitted to smuggling and distributing counterfeit cancer and hepatitis drugs into the US at the Southern District Court of Texas on July 17, according to the US Department of Justice.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
drugs, counterfeit, Keytruda, Ukraine, counterfeit drugs, FDA, Homeland Security, Merck & Co, Gilead, Bristol Myers Squibb, medication,
